Orion Pharma Ltd (ORIO)

Currency in BDT
31.90
-0.40(-1.24%)
Delayed Data·

ORIO Financial Summary

Key Ratios

P/E Ratio-57.54
Price/Book0.3
Debt / Equity106.14%
Return on Equity-0.63%
Dividend Yield3.13%
EBITDA1.50B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2014
31/12
2016
30/06
2017
30/06
2018
30/06
2019
30/06
2020
30/06
2021
30/06
2022
30/06
2023
30/06
2024
30/06
* In Millions of BDT (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.47%
Dividend Yield
3.17%
Industry Median 3.99%
Annualised payout
1.00
Paid annually
5-Years Growth
-7.79%
Growth Streak

Earnings

Latest Release
May 03, 2025
EPS / Forecast
0.02 / --
Revenue / Forecast
845.07M / --
EPS Revisions
Last 90 days

FAQ

What were Orion Pharma's earnings for the latest quarter?

The Orion Pharma EPS (TTM) is -0.47. Orion Pharma reported sales of 845.07, net income of 5.82, and EPS of 0.02 for the latest quarter.

What was Orion Pharma's net income for the latest quarter?

Orion Pharma's net income for the latest quarter was 5.82.

How did Orion Pharma's performance compare year-over-year in the latest quarter?

The company's revenue moved from 860.40 in the previous quarter to 845.07 in the latest quarter, and net income moved from -102.59 to 5.82 compared to the previous quarter.

What is Orion Pharma's net profit margin on a TTM basis?

Orion Pharma's trailing twelve months (TTM) net profit margin is 3.00%.

How does Orion Pharma's debt to equity ratio compare to industry standards?

Orion Pharma's total debt-to-equity ratio is 106.14%.

What is Orion Pharma's return on investment on a TTM basis?

Orion Pharma's trailing twelve months (TTM) return on investment (ROI) is -0.63%.

Did Orion Pharma gain or lose cash last quarter?

In the latest quarter, Orion Pharma's net change in cash was -23.69 million.

What were Orion Pharma's total assets and liabilities in the latest quarter?

As of the latest quarter, Orion Pharma reported total assets of 54,652.30 million and total liabilities of 8,600.43 million.

How has Orion Pharma's total revenue grown this year?

Orion Pharma's total revenue was 860.40 in the previous quarter and 845.07 in the latest quarter.

What is Orion Pharma's gross margin on a TTM basis?

Orion Pharma's trailing twelve months (TTM) gross margin is 28.94%.

What was Orion Pharma's revenue per share for the latest quarter?

Orion Pharma's revenue per share for the latest quarter was 134.41.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.